Caitong International Asset Management Co., LTD Kymera Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 2,467 shares of KYMR stock, worth $74,059. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,467Holding current value
$74,059% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding KYMR
# of Institutions
182Shares Held
66.9MCall Options Held
223KPut Options Held
241K-
Price T Rowe Associates Inc Baltimore, MD6.7MShares$201 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.46MShares$194 Million2.86% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$180 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$180 Million1.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.23MShares$157 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.64B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...